Cargando…

Expedited Desensitization to Canakinumab

INTRODUCTION: Interleukin-1 (IL-1) antagonists have been successful in the management of monogenic auto-inflammatory diseases, notably classic hereditary fever syndromes, such as Familial Mediterranean Fever (FMF). Anakinra (Kineret®), a human recombinant IL-1 receptor antagonist (IL-1Ra), has been...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sanan, Neha, Schend, Jason, Rowane, Marija, Hostoffer, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309336/ https://www.ncbi.nlm.nih.gov/pubmed/32612876 http://dx.doi.org/10.1177/2152656720937694

Ejemplares similares

Radiologic Contrast Media Desensitization for Delayed Cardiac Catheterization
por: Sanan, Neha, et al.
Publicado: (2019)

Something to Sweat About: Two Cases of Dupilumab-Induced Hyperhidrosis and Bromhidrosis
por: Rowane, Marija, et al.
Publicado: (2020)

Clinical Observation of COVID-19 in a Patient With an Acquired Humoral Deficiency Secondary to Chemotherapeutic Agents
por: Schend, Jason, et al.
Publicado: (2020)

Familial Success in Allergen Desensitization
por: Rowane, Marija, et al.
Publicado: (2019)

Post Autologous Bone Marrow Transplant Associated With a Resultant Mixed Polyclonal/Monoclonal Hyper-IgG3
por: Fill, Lauren, et al.
Publicado: (2020)

Successful Anti-SARS-CoV-2 Spike Protein Antibody Response to Vaccination in MAGT1 Deficiency
por: Jalil, Maaz, et al.
Publicado: (2021)

No Bull: A Case of Alpha-Gal Syndrome Associated With Buffalo Meat Sensitivity
por: Rowane, Marija, et al.
Publicado: (2019)

Posner-Schlossman Syndrome in Common Variable Immunodeficiency
por: Huq, Madiha, et al.
Publicado: (2020)

Treatment of refractory Yao syndrome with canakinumab
por: Brailsford, Caroline J., et al.
Publicado: (2022)

Canakinumab for refractory RA: a case report
por: Marketos, Nikolaos, et al.
Publicado: (2018)

A Case of Hyperimmunoglobulinemia D Syndrome Successfully Treated with Canakinumab
por: Tsitsami, Elena, et al.
Publicado: (2013)

Canakinumab as rescue therapy in familial Mediterranean fever refractory to conventional treatment
por: Alpa, Mirella, et al.
Publicado: (2015)

Increasing the Interval of Canakinumab Administration Effectively Supports the Remission of Schnitzler's Syndrome
por: Gorodetskiy, Vadim R., et al.
Publicado: (2018)

Canakinumab: Pulmonary bacterial superinfection secondary to compassionate use: case report
Publicado: (2021)

Desensitization to Adalimumab: An Example of Repeated Desensitization to a Biological Agent
por: Demirel, Fevzi, et al.
Publicado: (2015)

Successful treatment of refractory hyperferritinemic syndromes with canakinumab: a report of two cases
por: Papa, Riccardo, et al.
Publicado: (2020)

A case of Schnitzler’s syndrome without monoclonal gammopathy successfully treated with canakinumab
por: Fujita, Yuya, et al.
Publicado: (2021)

A case report of locally invasive Aspergillus fumigatus infection in a patient on canakinumab
por: Chandrakumaran, Anchalia, et al.
Publicado: (2018)

Improvement of Liver Involvement in Familial Mediterranean Fever After the Introduction of Canakinumab: A Case Report
por: Massaro, Maria Grazia, et al.
Publicado: (2020)

Case report on the use of canakinumab for treatment of recurrent fevers and proteinuria in refractory systemic lupus erythematosus
por: Yavari, Kimia, et al.
Publicado: (2023)

The experience of canakinumab in renal amyloidosis secondary to Familial Mediterranean fever
por: Sozeri, Betul, et al.
Publicado: (2016)

Report on the Expedition to the Central Mediterranean for the Study of Cosmic Radiation - Sardinian expedition 1953
por: European Council for Nuclear Research
Publicado: (1953)

OR10-006 - Canakinumab in patients with TRAPS
por: Lachmann, HJ, et al.
Publicado: (2013)

Canakinumab and Lung Cancer: Intriguing, but Is It Real?
por: Chabner, Bruce A., et al.
Publicado: (2018)

IgG3 Antibody Response to COVID-19 Vaccination in a Patient With a Large Heavy Chain Deletion
por: Sarkaria, Sandeep, et al.
Publicado: (2023)

IgM Deficiency Associated With Connexin Mutation in an 18-Year-old Male
por: Sarkaria, Sandeep, et al.
Publicado: (2023)

Live‐attenuated vaccines in a cryopyrin‐associated periodic syndrome patient receiving canakinumab treatment during infancy
por: Watanabe, Misa, et al.
Publicado: (2017)

Systemic autoimmune disease in asbestosis rapidly responding to anti-interleukin-1beta antibody canakinumab: a case report
por: Niccoli, Laura, et al.
Publicado: (2015)

Bilateral Episcleral Corkscrew Vessels: Expedition into the Unknown − Case Report
por: Madeira, Carolina, et al.
Publicado: (2022)

Eye Movement Desensitization and Reprocessing for Adolescent Depression
por: Bae, Hwallip, et al.
Publicado: (2008)

Successful Desensitization of a Patient with Rituximab Hypersensitivity
por: Ataca, Pinar, et al.
Publicado: (2015)

Rituximab and Canakinumab Use During Lactation: No Detectable Serum Levels in Breastfed Infants
por: Bosshard, Nicole, et al.
Publicado: (2021)

Expedition
Publicado: (1959)

Canakinumab and mycophenolate mofetil in managing proteinuria/renal amyloidosis secondary to adult-onset Still’s disease
por: Feng, Jin, et al.
Publicado: (2023)

Canakinumab in a subgroup of patients with COVID-19
por: Ucciferri, Claudio, et al.
Publicado: (2020)

PW01-012 – Canakinumab in patients with FMF
por: Ugurlu, S, et al.
Publicado: (2013)

Canakinumab for the treatment of different refractory autoinflammatory disorders
por: Grein, Ingrid HR, et al.
Publicado: (2014)

Canakinumab therapy in patients with Familial Mediterranean Fever
por: Ugurlu, S, et al.
Publicado: (2015)

Treatment of systemic-onset juvenile arthritis with canakinumab
por: Peitz, Joachim, et al.
Publicado: (2015)

Canakinumab and cardiovascular outcomes: results of the CANTOS trial
por: Shah, Syed Raza, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_69u9k92abus8a56m619g9m9vci